Hat mitgewirkt an:
-
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
-
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
-
The molecular basis of dystrophic Epidermolysis bullosa : mutation detection and study of clinical, biochemical and molecular findings in 29 patients
-
Systemic retinoids for treatment of recalcitrant IgA pemphigus